Evidence map›Paper›PMID 17194190›Full record

ArticlePLoS medicine2006

Impaired hepatitis C virus-specific T cell responses and recurrent hepatitis C virus in HIV coinfection.

Arthur Y Kim, Julian Schulze zur Wiesch, Thomas Kuntzen, Joerg Timm, Daniel E Kaufmann, Jared E Duncan, Andrea M Jones, Alysse G Wurcel, Benjamin T Davis, Rajesh T Gandhi and 5 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in PLoS medicine, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 91 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Spontaneous Clearance of the Hepatitis C Virus Among Men Who Have Sex With Men.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2015
    Observational
  12. Article
  13. Article
  14. HCV and HIV co-infection: mechanisms and management.Nature reviews. Gastroenterology & hepatology · 2014
    Review
  15. Article
  16. Direct effects of hepatitis C virus on the lymphoid cells.World journal of gastroenterology · 2013
    Review
  17. Observational
  18. HIV and co-infections.Immunological reviews · 2013
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Arthur Y KimPartners AIDS Research Center and Infectious Disease Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America. akim1@partners.org
Julian Schulze zur Wiesch
Thomas Kuntzen
Joerg Timm
Daniel E Kaufmann
Jared E Duncan
Andrea M Jones
Alysse G Wurcel
Benjamin T Davis
Rajesh T Gandhi
Gregory K Robbins
Todd M Allen
Raymond T Chung
Georg M Lauer
Bruce D Walker
Harvard University · USMassachusetts General Hospital · USHoward Hughes Medical Institute · USLemuel Shattuck Hospital · US

Funding

PROGRAM FOR AIDS CLINICAL RESEARCH TRAINING (PACRT)T32AI007433 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MARK J SIEDNER · 1992 to 2026
$11.4M
PARTNERS/FENWAY/SHATTUCK CENTER FOR AIDS RESEARCHP30AI042851 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI WALKER, BRUCE D · 2000 to 2003
$5.7M
CELL-MEDIATED IMMUNITY IN HEPATITIS C VIRUS INFECTIONR01AI031563 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI WALKER, BRUCE D · 1991 to 2005
$2.0M
Cell-mediated Immunity to HCV in HIV+ PersonsK23AI054379 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI KIM, ARTHUR Y · 2003 to 2007
$649k
NIAID NIH HHS AI 031563NIAID NIH HHS AI 042851NIAID NIH HHS AI 054379NIAID NIH HHS AI07433NIAID NIH HHS K23 AI054379NIAID NIH HHS P30 AI042851NIAID NIH HHS R01 AI031563NIAID NIH HHS T32 AI007433
6 · The paper itself

Abstract

backgroundHepatitis C virus (HCV)-specific T cell responses are critical for spontaneous resolution of HCV viremia. Here we examined the effect of a lymphotropic virus, HIV-1, on the ability of coinfected patients to maintain spontaneous control of HCV infection. METHODS AND

findingsWe measured T cell responsiveness by lymphoproliferation and interferon-gamma ELISPOT in a large cohort of HCV-infected individuals with and without HIV infection. Among 47 HCV/HIV-1-coinfected individuals, spontaneous control of HCV was associated with more frequent HCV-specific lymphoproliferative (LP) responses (35%) compared to coinfected persons who exhibited chronic HCV viremia (7%, p = 0.016), but less frequent compared to HCV controllers who were not HIV infected (86%, p = 0.003). Preservation of HCV-specific LP responses in coinfected individuals was associated with a higher nadir CD4 count (r(2) = 0.45, p < 0.001) and the presence and magnitude of the HCV-specific CD8(+) T cell interferon-gamma response (p = 0.0014). During long-term follow-up, recurrence of HCV viremia occurred in six of 25 coinfected individuals with prior control of HCV, but in 0 of 16 HIV-1-negative HCV controllers (p = 0.03, log rank test). In these six individuals with recurrent HCV viremia, the magnitude of HCV viremia following recurrence inversely correlated with the CD4 count at time of breakthrough (r = -0.94, p = 0.017).

conclusionsThese results indicate that HIV infection impairs the immune response to HCV-including in persons who have cleared HCV infection-and that HIV-1-infected individuals with spontaneous control of HCV remain at significant risk for a second episode of HCV viremia. These findings highlight the need for repeat viral RNA testing of apparent controllers of HCV infection in the setting of HIV-1 coinfection and provide a possible explanation for the higher rate of HCV persistence observed in this population.

Indexed as

CD4-Positive T-LymphocytesComorbidityCross-Sectional StudiesHepacivirusHepatitis CHIV-1HIV Core Protein p24HumansImmunoassayInterferon-gammaLymphocyte CountRecurrenceRNA, ViralViremiaHIV Core Protein p24Interferon-gammaRNA, Viral

Identifiers

PMID17194190
PMCPMC1705826
OpenAlexW2130624256

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.